| Identification | |
| Name: | AKTI-1/2 |
| CAS: | 612847-09-3 |
| Molecular Formula: | C34H29N7O |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C34H29N7O/c42-34-39-26-8-4-5-9-31(26)41(34)25-14-16-40(17-15-25)20-22-10-12-24(13-11-22)33-32(23-6-2-1-3-7-23)37-29-18-27-28(36-21-35-27)19-30(29)38-33/h1-13,18-19,21,25H,14-17,20H2,(H,35,36)(H,39,42) |
| Molecular Structure: | ![(C34H29N7O) 1,3-Dihydro-1-[1-[[4-(6-phenyl-1H-imidazo[4,5-g]guinoxalin-7-yl)phenyl]methyl]4-piperidinyl]-2H-benz...](https://img.guidechem.com/structure/612847-09-3.gif) |
| Properties | |
| Density: | 1.351g/cm3 |
| Refractive index: | 1.734 |
| Appearance: | Pale yellow solid |
| Usage: | Allosteric Akt (PKB) inhibitors used in synergistic combination therapy for the treatment of cancer |
| Safety Data | |
 |
|
